Steve Elms, Director at AMBIT BIOSCIENCES CORP (AMBI), bought 481,083 shares at $8.00 ($3.4M) on 2013-05-21, disclosed to the SEC on 2013-05-21.
Open-market purchase of $3.4M AMBI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 57,448 | $0 | 0.0% |
| 2 | $8.00 | 423,635 | $3.4M | 100.0% |
| Total | $7.04 avg | 481,083 | $3.4M | 100% |
| Filing → |
| MRKR | BUY | 2024-12-26 | $35K | — | Filing → |
| ADMA | SELL | 2024-03-19 | $5.6M | — | Filing → |
| ADMA | SELL | 2024-03-15 | $10.2M | — | Filing → |